Skip to main content

For people 6+ with moderate to severe plaque psoriasis

Purple to pink gradient background

10 YEARS OF HELPING PEOPLE LOOK AND FEEL BETTER WITH COSENTYX® (secukinumab)

Results fast. Clear skin that can last.

Clinically studied for 18 years, and FDA approved for over 10, COSENTYX is a proven treatment prescribed by doctors to help clear skin.

In plaque psoriasis clinical trials, 6 out of 10 people taking COSENTYX 300 mg were clear or almost clear at 12 weeks. Approximately 8 out of 10 people saw 75% skin clearance vs ~5% taking placebo. Approximately 6 out of 10 people saw 90% skin clearance vs 1% taking placebo.

Many who saw results at 1 year maintained them at 5 years.§

Across all indications combined.
§After 3 years, patients and doctors were told which medication was being used. Knowing the study drug being used may affect the results.

90% skin clearance at 12 weeks, 1 year, and 5 years

Among those moderate to severe plaque psoriasis patients who kept a symptom diary (39% of people), people taking COSENTYX reported an improvement in symptoms like pain, itching, and scaling at 12 weeks, compared with those not taking COSENTYX (placebo) in the studies.

COSENTYX also improves troublesome areas like scalp and nails.

Nail and scalp psoriasis can mean a higher risk of psoriatic arthritis, another potential related disease.

See how both conditions may be connected and if you're at risk.

See before and after pictures of how COSENTYX works on troublesome areas, like the scalp, nails, palms, and bottoms of feet.

.

Plaque psoriasis treatment on scalp before and after COSENTYX

Scalp

Plaque psoriasis treatment on nails before and after COSENTYX

Nails

Plaque psoriasis treatment on palms before and after COSENTYX

Palms

Plaque psoriasis treatment on bottom of feet before and after COSENTYX

Bottoms of feet

||At week 12, 53% of people on COSENTYX 300 mg saw 90% scalp clearance compared with 2% taking placebo.
Nail psoriasis improved by 46% in people receiving COSENTYX 300 mg compared to an improvement of about 12% in people receiving placebo at week 16.
#Over 30% of people on COSENTYX 300 mg were clear or almost clear on their palms and the bottoms of their feet at 16 weeks compared to 1.5% with placebo.
 

Real people are seeing and feeling real results, even on troublesome areas:

Nadia actual patient

Individual results may vary. Nadia was compensated for her time.

“One time, in particular, I was at a hair salon getting ready to be serviced, and the beautician who was about to do my hair was very disrespectful. I assumed that the psoriasis made her feel uncomfortable."


"Things that have changed for me personally would include: I have a clear scalp. I have no more flakes. I don’t have to be so mindful with the colors that I wear. I can easily get my hair done.”

Dewey actual patient

Individual results may vary. Dewey was compensated for his time. 

“I had it all the way up to the fingertips, including the nails. At the cashout line, the cashier would ask me to pay with a card so she wouldn’t have to touch my money. That was everyday life.”


"Now it’s the best feeling to be in public. I’m clear.”

What’s the connection between plaque psoriasis and psoriatic arthritis?

Many people with plaque psoriasis may develop psoriatic arthritis, especially if they have psoriasis on their nails and scalp. 

In a trial of patients with psoriatic arthritis, about 60% of patients taking COSENTYX 150 mg or 300 mg (versus 18% of patients taking placebo) saw at least a 20% improvement in psoriatic arthritis symptoms at 16 weeks. 

If left untreated, psoriatic arthritis can cause permanent joint damage.

For 10 years, doctors have prescribed COSENTYX because it has worked to treat all of this and help stop further joint damage.

84% icon

84% of people with psoriatic arthritis taking COSENTYX experienced no further joint damage at the 2-year mark.**

**About 76% of patients taking COSENTYX 150 mg or 300 mg had no further joint damage at the hands, wrists, and feet at Week 24, compared to 68% taking placebo. Everyone's experience is different. These results were from a less rigorous analysis, so it is not known if symptom improvement was due to COSENTYX. At 2 years, 84% of patients taking COSENTYX 300 mg had no further joint damage (71% of patients taking COSENTYX 150 mg).

THERE IS HOPE: MEET NADIA

See how Nadia, a real patient who lives with plaque psoriasis, never gave up hope—for herself and also for her daughter, Lola.

And to get to know our patient advocates even better, watch more COSENTYX stories on our patient video page.

Individual results may vary. All participants were compensated for their time.

*Limitations apply. Subject to annual co-pay benefit limit. Offer not valid under Medicare, Medicaid, or any other federal or state programs. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions for details.